Selected research
Industry Research
Metamizole Sodium Injection Industry Research Report 2026
Market perspective
The global Metamizole Sodium Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metamizole Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metamizole Sodium Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metamizole Sodium Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metamizole Sodium Injection include Teva Pharmaceutical, Sanofi, Novartis, WAMIN, Taj Life Sciences, Reyoung Pharma, Naman Pharma Drugs, MSD and Montage Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metamizole Sodium Injection market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metamizole Sodium Injection Market by Company
Teva Pharmaceutical
Sanofi
Novartis
WAMIN
Taj Life Sciences
Reyoung Pharma
Naman Pharma Drugs
MSD
Montage Laboratories
Krosyl Pharmaceutical
Drag Pharma
Centurion Healthcare
Bhumi Pharmaceuticals
AdvaCare Pharma
Metamizole Sodium Injection Segment by Type
500mg/1ml
1000mg/2 ml
Metamizole Sodium Injection Segment by Application
Hospital
Research Institute
Metamizole Sodium Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metamizole Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metamizole Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metamizole Sodium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metamizole Sodium Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metamizole Sodium Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metamizole Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg/1ml
- 1000mg/2 ml
Applications
- Hospital
- Research Institute
Companies covered
- Teva Pharmaceutical
- Sanofi
- Novartis
- WAMIN
- Taj Life Sciences
- Reyoung Pharma
- Naman Pharma Drugs
- MSD
- Montage Laboratories
- Krosyl Pharmaceutical
- Drag Pharma
- Centurion Healthcare
- Bhumi Pharmaceuticals
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metamizole Sodium Injection Market Size (2021-2032)
- 2.2.2 Global Metamizole Sodium Injection Sales (2021-2032)
- 2.2.3 Global Metamizole Sodium Injection Market Average Price (2021-2032)
- 2.3 Metamizole Sodium Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 500mg/1ml
- 2.3.3 1000mg/2 ml
- 2.4 Metamizole Sodium Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Research Institute
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metamizole Sodium Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metamizole Sodium Injection Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Metamizole Sodium Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Metamizole Sodium Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Metamizole Sodium Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metamizole Sodium Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metamizole Sodium Injection, Product Type & Application
- 3.8 Global Manufacturers of Metamizole Sodium Injection, Established Date
- 3.9 Global Metamizole Sodium Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Metamizole Sodium Injection Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Metamizole Sodium Injection Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Metamizole Sodium Injection Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 WAMIN
- 4.4.1 WAMIN Company Information
- 4.4.2 WAMIN Business Overview
- 4.4.3 WAMIN Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 WAMIN Metamizole Sodium Injection Product Portfolio
- 4.4.5 WAMIN Recent Developments
- 4.5 Taj Life Sciences
- 4.5.1 Taj Life Sciences Company Information
- 4.5.2 Taj Life Sciences Business Overview
- 4.5.3 Taj Life Sciences Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taj Life Sciences Metamizole Sodium Injection Product Portfolio
- 4.5.5 Taj Life Sciences Recent Developments
- 4.6 Reyoung Pharma
- 4.6.1 Reyoung Pharma Company Information
- 4.6.2 Reyoung Pharma Business Overview
- 4.6.3 Reyoung Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Reyoung Pharma Metamizole Sodium Injection Product Portfolio
- 4.6.5 Reyoung Pharma Recent Developments
- 4.7 Naman Pharma Drugs
- 4.7.1 Naman Pharma Drugs Company Information
- 4.7.2 Naman Pharma Drugs Business Overview
- 4.7.3 Naman Pharma Drugs Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Naman Pharma Drugs Metamizole Sodium Injection Product Portfolio
- 4.7.5 Naman Pharma Drugs Recent Developments
- 4.8 MSD
- 4.8.1 MSD Company Information
- 4.8.2 MSD Business Overview
- 4.8.3 MSD Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MSD Metamizole Sodium Injection Product Portfolio
- 4.8.5 MSD Recent Developments
- 4.9 Montage Laboratories
- 4.9.1 Montage Laboratories Company Information
- 4.9.2 Montage Laboratories Business Overview
- 4.9.3 Montage Laboratories Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Montage Laboratories Metamizole Sodium Injection Product Portfolio
- 4.9.5 Montage Laboratories Recent Developments
- 4.10 Krosyl Pharmaceutical
- 4.10.1 Krosyl Pharmaceutical Company Information
- 4.10.2 Krosyl Pharmaceutical Business Overview
- 4.10.3 Krosyl Pharmaceutical Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Krosyl Pharmaceutical Metamizole Sodium Injection Product Portfolio
- 4.10.5 Krosyl Pharmaceutical Recent Developments
- 4.11 Drag Pharma
- 4.11.1 Drag Pharma Company Information
- 4.11.2 Drag Pharma Business Overview
- 4.11.3 Drag Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Drag Pharma Metamizole Sodium Injection Product Portfolio
- 4.11.5 Drag Pharma Recent Developments
- 4.12 Centurion Healthcare
- 4.12.1 Centurion Healthcare Company Information
- 4.12.2 Centurion Healthcare Business Overview
- 4.12.3 Centurion Healthcare Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Centurion Healthcare Metamizole Sodium Injection Product Portfolio
- 4.12.5 Centurion Healthcare Recent Developments
- 4.13 Bhumi Pharmaceuticals
- 4.13.1 Bhumi Pharmaceuticals Company Information
- 4.13.2 Bhumi Pharmaceuticals Business Overview
- 4.13.3 Bhumi Pharmaceuticals Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bhumi Pharmaceuticals Metamizole Sodium Injection Product Portfolio
- 4.13.5 Bhumi Pharmaceuticals Recent Developments
- 4.14 AdvaCare Pharma
- 4.14.1 AdvaCare Pharma Company Information
- 4.14.2 AdvaCare Pharma Business Overview
- 4.14.3 AdvaCare Pharma Metamizole Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 AdvaCare Pharma Metamizole Sodium Injection Product Portfolio
- 4.14.5 AdvaCare Pharma Recent Developments
5 Global Metamizole Sodium Injection Market Scenario by Region
- 5.1 Global Metamizole Sodium Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metamizole Sodium Injection Sales by Region: 2021-2032
- 5.2.1 Global Metamizole Sodium Injection Sales by Region: 2021-2026
- 5.2.2 Global Metamizole Sodium Injection Sales by Region: 2027-2032
- 5.3 Global Metamizole Sodium Injection Revenue by Region: 2021-2032
- 5.3.1 Global Metamizole Sodium Injection Revenue by Region: 2021-2026
- 5.3.2 Global Metamizole Sodium Injection Revenue by Region: 2027-2032
- 5.4 North America Metamizole Sodium Injection Market Facts & Figures by Country
- 5.4.1 North America Metamizole Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metamizole Sodium Injection Sales by Country (2021-2032)
- 5.4.3 North America Metamizole Sodium Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Metamizole Sodium Injection Market Facts & Figures by Country
- 5.5.1 Europe Metamizole Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metamizole Sodium Injection Sales by Country (2021-2032)
- 5.5.3 Europe Metamizole Sodium Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Metamizole Sodium Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metamizole Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metamizole Sodium Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metamizole Sodium Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metamizole Sodium Injection Market Facts & Figures by Country
- 5.7.1 South America Metamizole Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metamizole Sodium Injection Sales by Country (2021-2032)
- 5.7.3 South America Metamizole Sodium Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Metamizole Sodium Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metamizole Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metamizole Sodium Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metamizole Sodium Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Metamizole Sodium Injection Sales by Type (2021-2032)
- 6.1.1 Global Metamizole Sodium Injection Sales by Type (2021-2032) & (L)
- 6.1.2 Global Metamizole Sodium Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Metamizole Sodium Injection Revenue by Type (2021-2032)
- 6.2.1 Global Metamizole Sodium Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metamizole Sodium Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Metamizole Sodium Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metamizole Sodium Injection Sales by Application (2021-2032)
- 7.1.1 Global Metamizole Sodium Injection Sales by Application (2021-2032) & (L)
- 7.1.2 Global Metamizole Sodium Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Metamizole Sodium Injection Revenue by Application (2021-2032)
- 7.2.1 Global Metamizole Sodium Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metamizole Sodium Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Metamizole Sodium Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metamizole Sodium Injection Value Chain Analysis
- 8.1.1 Metamizole Sodium Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metamizole Sodium Injection Production Mode & Process
- 8.2 Metamizole Sodium Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metamizole Sodium Injection Distributors
- 8.2.3 Metamizole Sodium Injection Customers
9 Global Metamizole Sodium Injection Analyzing Market Dynamics
- 9.1 Metamizole Sodium Injection Industry Trends
- 9.2 Metamizole Sodium Injection Industry Drivers
- 9.3 Metamizole Sodium Injection Industry Opportunities and Challenges
- 9.4 Metamizole Sodium Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst